Cargando…
Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585560/ https://www.ncbi.nlm.nih.gov/pubmed/34775132 http://dx.doi.org/10.1016/j.jgar.2021.09.014 |
| _version_ | 1784597716831043584 |
|---|---|
| author | Adams, Briony Beaney, Alec |
| author_facet | Adams, Briony Beaney, Alec |
| author_sort | Adams, Briony |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8585560 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85855602021-11-12 Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy Adams, Briony Beaney, Alec J Glob Antimicrob Resist Article The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. 2021-12 2021-11-12 /pmc/articles/PMC8585560/ /pubmed/34775132 http://dx.doi.org/10.1016/j.jgar.2021.09.014 Text en © 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Adams, Briony Beaney, Alec Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy |
| title | Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy |
| title_full | Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy |
| title_fullStr | Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy |
| title_full_unstemmed | Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy |
| title_short | Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy |
| title_sort | interpreting serum procalcitonin in covid-19 patients undergoing renal replacement therapy |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585560/ https://www.ncbi.nlm.nih.gov/pubmed/34775132 http://dx.doi.org/10.1016/j.jgar.2021.09.014 |
| work_keys_str_mv | AT adamsbriony interpretingserumprocalcitoninincovid19patientsundergoingrenalreplacementtherapy AT beaneyalec interpretingserumprocalcitoninincovid19patientsundergoingrenalreplacementtherapy |